GlobeNewswire: STRATA Skin Sciences, Inc. Contains the last 10 of 211 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T21:32:08ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/03/27/2853596/0/en/STRATA-Skin-Sciences-Reports-Fourth-Quarter-and-Full-Year-2023-Earnings.html?f=22&fvtc=4&fvtv=17650STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings2024-03-27T20:01:00Z<![CDATA[Company to host conference call and webcast today, March 27, 2024, at 4:30 PM ET Company to host conference call and webcast today, March 27, 2024, at 4:30 PM ET]]>https://www.globenewswire.com/news-release/2024/03/13/2845351/0/en/STRATA-Skin-Sciences-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results-on-March-27-2024.html?f=22&fvtc=4&fvtv=17650STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 20242024-03-13T12:00:00Z<![CDATA[HORSHAM, Pa., March 13, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced it plans to release its fourth quarter and full-year 2023 financial results on Wednesday, March 27, 2024. Management will hold a conference call to review the financial results and provide a corporate update at 4:30 PM ET on the same day.]]>https://www.globenewswire.com/news-release/2024/03/07/2842187/0/en/STRATA-Skin-Sciences-Announces-Initiative-to-Expand-Treatment-Coverage.html?f=22&fvtc=4&fvtv=17650STRATA Skin Sciences Announces Initiative to Expand Treatment Coverage2024-03-07T13:00:00Z<![CDATA[HORSHAM, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced an initiative aimed at expanding insurance coverage for essential treatments for conditions such as mycosis fungoides, lichen planus, alopecia areata, and cutaneous T-Cell lymphoma (CTCL), with an initial targeted focus on expanding coverage for vitiligo and atopic dermatitis, skin diseases effecting up to 3 and 16 million people in the United States respectively1. The Company is leveraging its extensive patient database and engaging in targeted governmental relations efforts, this initiative focuses on broadening Current Procedural Terminology (“CPT”) code coverage to increase patient access to advanced treatments and enable higher provider reimbursement rates.]]>https://www.globenewswire.com/news-release/2024/02/26/2835474/0/en/STRATA-Skin-Sciences-Announces-Successful-Amendment-to-Credit-Agreement-with-MidCap-Financial.html?f=22&fvtc=4&fvtv=17650STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial2024-02-26T21:01:00Z<![CDATA[–Amends certain financial covenants to enhance liquidity and financial flexibility– –Ensures alignment with the Company’s current and future business operations–]]>https://www.globenewswire.com/news-release/2024/01/08/2805403/0/en/STRATA-Skin-Sciences-to-Present-Poster-Showcasing-Safety-and-Efficacy-of-TheraClear-X-for-Acne-at-Maui-Derm-2024-Conference.html?f=22&fvtc=4&fvtv=17650STRATA Skin Sciences to Present Poster Showcasing Safety and Efficacy of TheraClear®X for Acne at Maui Derm 2024 Conference 2024-01-08T13:00:00Z<![CDATA[HORSHAM, Pa., Jan. 08, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that the Company will be presenting a poster titled “Pulsed Broadband Light with Vacuum Suction (Photopneumatic Therapy) and Needle Insert to Treat Acne” at the Maui Derm 2024 Meeting to be held at the Grand Wailea in Maui, Hawaii from January 22-26, 2024.]]>https://www.globenewswire.com/news-release/2024/01/03/2803243/0/en/STRATA-Skin-Granted-Extension-by-Nasdaq-to-Regain-Compliance-with-Minimum-Bid-Requirement.html?f=22&fvtc=4&fvtv=17650STRATA Skin Granted Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement2024-01-03T13:00:00Z<![CDATA[HORSHAM, Pa., Jan. 03, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it has received a notification letter (“Notice”) from Nasdaq Stock Market LLC (“Nasdaq”) that the Company has been granted a 180-day extension, or until June 24, 2024, to regain compliance with Nasdaq’s minimum bid price rule.]]>https://www.globenewswire.com/news-release/2023/12/29/2802046/0/en/STRATA-Skin-Sciences-Announces-Expansion-of-Distribution-Agreement-with-Kosmo-Meditech.html?f=22&fvtc=4&fvtv=17650STRATA Skin Sciences Announces Expansion of Distribution Agreement with Kosmo Meditech2023-12-29T13:00:00Z<![CDATA[Agreement further solidifies the strength and growth of the partnership between STRATA Skin Sciences and Kosmo Meditech Agreement further solidifies the strength and growth of the partnership between STRATA Skin Sciences and Kosmo Meditech]]>https://www.globenewswire.com/news-release/2023/12/04/2789955/0/en/STRATA-Skin-Science-Announces-Strengthening-of-Leadership-Team.html?f=22&fvtc=4&fvtv=17650STRATA Skin Science Announces Strengthening of Leadership Team2023-12-04T13:00:00Z<![CDATA[Shmuel Gov Promoted to Chief Operating Officer]]>https://www.globenewswire.com/news-release/2023/12/01/2789268/0/en/STRATA-Skin-Sciences-to-Participate-in-the-Benchmark-12th-Annual-Discovery-One-on-One-Investor-Conference.html?f=22&fvtc=4&fvtv=17650STRATA Skin Sciences to Participate in the Benchmark 12th Annual Discovery One-on-One Investor Conference2023-12-01T13:00:00Z<![CDATA[HORSHAM, Pa., Dec. 01, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that the company will be participating in the Benchmark 12th Annual Discovery One-on-One Investor Conference being held in New York City on December 7, 2023. Details for the event are as follows:]]>https://www.globenewswire.com/news-release/2023/11/14/2780469/0/en/STRATA-Skin-Sciences-Reports-Third-Quarter-2023-Revenue.html?f=22&fvtc=4&fvtv=17650STRATA Skin Sciences Reports Third Quarter 2023 Revenue2023-11-14T21:00:00Z<![CDATA[Company to Host Conference Call and Webcast Today, November 14, 2023, at 4:30 PM ET Company to Host Conference Call and Webcast Today, November 14, 2023, at 4:30 PM ET]]>